Pages that link to "Q44042068"
Jump to navigation
Jump to search
The following pages link to Addition of inhaled corticosteroids to systemic immunosuppression after lung transplantation: a double-blind, placebo-controlled trial. (Q44042068):
Displaying 20 items.
- What's new in clinical solid organ transplantation by 2013. (Q34761349) (← links)
- Bronchiolitis obliterans (Q35625678) (← links)
- Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies (Q36093259) (← links)
- Ciclosporin aerosol in lung transplantation (Q36543083) (← links)
- Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome (Q36640114) (← links)
- Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation (Q36712018) (← links)
- Immunosuppression for lung transplantation: evidence to date (Q36895529) (← links)
- How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation (Q37609903) (← links)
- The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation (Q37796528) (← links)
- Conventional and Novel Approaches to Immunosuppression (Q37867760) (← links)
- Adverse effects of immunosuppressant drugs upon airway epithelial cell and mucociliary clearance: implications for lung transplant recipients (Q38120665) (← links)
- Immunosuppression and allograft rejection following lung transplantation: evidence to date (Q38154197) (← links)
- Recent immunomodulatory strategies in transplantation (Q38258157) (← links)
- Non-infectious respiratory disease in non-HIV immunocompromised patients. (Q38285559) (← links)
- Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges. (Q38544028) (← links)
- The potential role of activin and follistatin in lung transplant dysfunction. (Q38606852) (← links)
- Lung microbiomes: new frontiers? (Q42549165) (← links)
- Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients (Q44829185) (← links)
- Prevention of chronic rejection after lung transplantation (Q47662940) (← links)
- Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas (Q75410348) (← links)